Close
Nordic 9Nordic 9

Cumulus Oncology (investor - Others)

United Kingdom cumulusoncology.com
See something wrong or missing? Let us know
Offices:Edinburgh

Cumulus Oncology is a oncology biotech creation studio from the UK, founded by Dr Clare Wareing (CEO) in 2017.

Average round investment:2.91M USD
Average number per year:1.0
Distribution: 2023 (1)
Portfolio companies: United Kingdom Nodus Oncology
Mostly invests in: United Kingdom United Kingdom (1) Health services (1)

1 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Cumulus Oncology

Name Criteria
United Kingdom Catapult Ventures
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Germany KHAN Technology Transfer Fund
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Israel Nadav Rosenberg
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
Sweden Enexis AB
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United Kingdom Jude Gomila
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
France Oskare Capital
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
United Kingdom Simon Franks
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.1
  • Active last 12 months: Yes
United Kingdom Rockmount Capital
82%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.5
  • Active last 12 months: Yes
United Kingdom Beast Ventures
82%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United Kingdom Scottish Investment Bank
82%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 3.7
  • Active last 12 months: Yes
Top